Matinas Biopharma Holdings, Inc.
MTNB
Revenue
1.10M
▲33.00k▲3.10%
6 Months ChangeAssets
24.37M
▲4.76M▲24.25%
3 Months ChangeLiabilities
5.26M
▲210.00k▲4.16%
3 Months ChangeFree Cash Flow
-5.30M
▼-630.71k▼-13.50%
24 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-31
Form 8-K
ID: 0001493152-24-043130
2024-10-24
Form 8-K
ID: 0001493152-24-042277
2024-09-03
Form 8-K
ID: 0001493152-24-034729
2024-08-28
Form 8-K
ID: 0001493152-24-034098
2024-08-20
Form 8-K
ID: 0001493152-24-033263
2024-08-14
Form 8-K
ID: 0001493152-24-032189
2024-08-14
Form 10-Q
ID: 0001493152-24-032144
2024-05-09
Form 8-K
ID: 0001493152-24-018428
2024-05-09
Form 10-Q
ID: 0001493152-24-018417
2024-04-05
Form 8-K
ID: 0001493152-24-013255